KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | +200.0% | 607 | +205.0% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 199 | -81.5% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 1,076 | -39.1% | 0.00% | – |
| Q4 2021 | $11,000 | 0.0% | 1,768 | -6.8% | 0.00% | – |
| Q3 2021 | $11,000 | -31.2% | 1,897 | +22.3% | 0.00% | -100.0% |
| Q2 2021 | $16,000 | +6.7% | 1,551 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $15,000 | -11.8% | 1,454 | +32.2% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | +750.0% | 1,100 | +558.7% | 0.00% | – |
| Q3 2020 | $2,000 | -60.0% | 167 | -39.9% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 278 | +56.2% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 178 | -32.1% | 0.00% | – |
| Q4 2019 | $5,000 | – | 262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |